These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 29230217)
1. Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences. Donovan ML; Schultz TE; Duke TJ; Blumenthal A Front Immunol; 2017; 8():1633. PubMed ID: 29230217 [TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. [Evolution of IGRA researches]. Ariga H; Harada N Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999 [TBL] [Abstract][Full Text] [Related]
5. Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection. Travar M; Petkovic M; Verhaz A Arch Immunol Ther Exp (Warsz); 2016 Feb; 64(1):19-31. PubMed ID: 26362801 [TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Sahiratmadja E; Alisjahbana B; de Boer T; Adnan I; Maya A; Danusantoso H; Nelwan RH; Marzuki S; van der Meer JW; van Crevel R; van de Vosse E; Ottenhoff TH Infect Immun; 2007 Feb; 75(2):820-9. PubMed ID: 17145950 [TBL] [Abstract][Full Text] [Related]
7. MiR-23a-5p modulates mycobacterial survival and autophagy during mycobacterium tuberculosis infection through TLR2/MyD88/NF-κB pathway by targeting TLR2. Gu X; Gao Y; Mu DG; Fu EQ Exp Cell Res; 2017 May; 354(2):71-77. PubMed ID: 28327409 [TBL] [Abstract][Full Text] [Related]
8. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414 [TBL] [Abstract][Full Text] [Related]
9. Role of Interferons in Shanmuganathan G; Orujyan D; Narinyan W; Poladian N; Dhama S; Parthasarathy A; Ha A; Tran D; Velpuri P; Nguyen KH; Venketaraman V Clin Pract; 2022 Sep; 12(5):788-796. PubMed ID: 36286068 [TBL] [Abstract][Full Text] [Related]
10. Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology. Chandra P; Rajmani RS; Verma G; Bhavesh NS; Kumar D mSphere; 2016; 1(2):. PubMed ID: 27303736 [TBL] [Abstract][Full Text] [Related]
12. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects. Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040 [TBL] [Abstract][Full Text] [Related]
13. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Jo EK Curr Opin Infect Dis; 2008 Jun; 21(3):279-86. PubMed ID: 18448973 [TBL] [Abstract][Full Text] [Related]
14. Autophagy as an innate defense against mycobacteria. Jo EK Pathog Dis; 2013 Mar; 67(2):108-18. PubMed ID: 23620156 [TBL] [Abstract][Full Text] [Related]
15. Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases. Mourik BC; Lubberts E; de Steenwinkel JEM; Ottenhoff THM; Leenen PJM Front Immunol; 2017; 8():294. PubMed ID: 28424682 [TBL] [Abstract][Full Text] [Related]